News

Dübendorf ZH – Fluorine-rich salts make recycling lithium-ion batteries a dangerous and complicated process. Empa researchers have now turned their attention towards solving this problem. To this end, they have already developed a new, non-combustible, water-based electrolyte.

Pfäffikon SZ/Schlieren ZH – The life sciences company DiNAQOR is moving into new research premises at the Bio-Technopark Schlieren-Zurich this fall. The company is planning to drive forward the development of genetic therapies for the treatment of cardiac diseases from its new base.

Zug - The FinTech start-up vestr has closed an oversubscribed Series A financing round under the leadership of the SIX Group. The firm offers software services to the financial industry. It is planning to put the fresh capital towards the further development of its platform.

Winterthur – After years of development work, the first two Bro model power wheelchairs have been delivered by the start-up Scewo. The Scewo Bro is even able to independently climb stairs without the help of an accompanying person.

Rümlang/Stäfa ZH – The two ETH spin-offs GreenTEG and u-blox are jointly launching a new wearable device. This thermometer will be able to continually measure the wearer’s core body temperature. It is aimed at facilitating a safe return to the workplace after the coronavirus crisis.

Schlieren ZH - Virometix has secured funding in the amount of 7.5 million Swiss francs after closing a Series B financing round. The company intends to use the injection of fresh capital to drive forward the development of its coronavirus vaccine candidates, among other plans.

Zurich/Winterthur – Researchers at ETH Zurich and the ZHAW have developed a simple method for precisely mapping resistance exercise on machines. This could be used to develop optimized training strategies for muscular atrophy, for example. The method might also help in creating digitalized training facilities.

Zurich – Researchers at the University of Zurich have determined the three-dimensional structure of the receptor to which the “cuddle hormone” oxytocin binds. It is hoped this knowledge will facilitate the development of novel drugs.

Andreas Schönenberger, CEO of Sanitas Health Insurance, is a new member of the Board of Directors of the investment promotion agency Greater Zurich Area Ltd (GZA). The accession of the Cham Group real estate company and the flexible workspace provider IWG to the public-private ownership of GZA will further strengthen the marketing of the Greater Zurich Area abroad.